talactoferrin alfa: Clinical Trials

3 trials of talactoferrin alfa, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 suspended, 1 unknown. 3 Phase 3, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 33Completed 1, Suspended 1, Unknown 1
Phase 21Suspended 1

Follow talactoferrin alfa: new trials by email Literature Review of talactoferrin alfa trials Research Report on talactoferrin alfa

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Safety and Efficacy of Talactoferrin Alfa in Patients With Severe Sepsis
Talactoferrin alfa, Placebo - Severe Sepsis
Phase 2 / Phase 3SuspendedAgennix12802011-06-012012-02-03
Safety and Efficacy of Talactoferrin in Addition to Standard Chemotherapy in Patients With Non-small Cell Lung Cancer
Talactoferrin, Placebo - Non Small Cell Lung Cancer
Phase 3UnknownAgennix11002009-02-012012-03-15
Safety and Efficacy of Talactoferrin in Previously Treated Patients With Non-small Cell Lung Cancer
Talactoferrin, Placebo - Non Small Cell Lung Cancer
Phase 3CompletedAgennix7422008-11-012012-08-21

Conditions studied

Carcinoma, Non-Small-Cell Lung (2)  ·  Sepsis (1)

Sponsors

Agennix (3)

Countries

United States (3)  ·  Canada (2)  ·  France (2)  ·  Germany (2)  ·  Spain (2)  ·  United Kingdom (2)  ·  Australia (1)  ·  Belgium (1)  ·  Bulgaria (1)  ·  Czechia (1)  ·  Denmark (1)  ·  Greece (1)  ·  Hungary (1)  ·  India (1)  ·  Israel (1)

Results publications

PMID 26010687